Antiobesity effects of an edible halophyte Nitraria retusa Forssk in 3T3-L1 preadipocyte differentiation and in C57B6J/L mice fed a high fat diet-induced obesity

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zar Kalai, Feten ^a   Han, Junkyu ^a   Ksouri, Riadh ^b   El Omri, Abdelfatteh ^a   Abdelly, Chedly ^b   Isoda, Hiroko ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CENTRE DE BIOTECHNOLOGIE DE BORJ CÉDRIA   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893814280     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/368658     Document Type: Article

References (44)

1. WHO, Traditional Medicune Strategy 2002 Geneva, Switzerland WHO
2. Patricia M., Donohoue A., Energy Metabolism and Obesity: Research and Clinical Applications 2008 Springer
3. Dave S., Kaur N. J., Nanduri R., Dkhar H. K., Kumar A., Gupta P., Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes. PLoS ONE 2012 7 1 2-s2.0-84856158975 10.1371/journal.pone.0030831 e30831
4. Dridi S., Taouis M., Adiponectin and energy homeostasis: consensus and controversy. Journal of Nutritional Biochemistry 2009 20 11 831 839 2-s2.0-71749118034 10.1016/j.jnutbio.2009.06.003
5. Inadera H., The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. International Journal of Medical Sciences 2008 5 5 248 262 2-s2.0-51449099389
6. van den Berghe G., The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism. Journal of Inherited Metabolic Disease 1991 14 4 407 420 2-s2.0-0025768055
7. Radonjic M., de Haan J. R., van Erk M. J., van Dijk K. W., van den Berg S. A. A., de Groot P. J., Müller M., van Ommen B., Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program. PLoS ONE 2009 4 8 2-s2.0-69949089784 10.1371/journal.pone.0006646 e6646
8. Sahib N. A. G., Saari N., Ismail A., Khatib A., Mahomoodally F., Abdul Hamid A., Plants' metabolites as potential antiobesity agents. The Scientific World Journal 2012 2012 8 436039 10.1100/2012/436039
9. Tomoyasu Kamiya, Mayu Sameshima-Kamiya, Rika Nagamine, The crude extract from puerariae flower exerts anti-obesity and anti-fatty liver effects in high-fat diet-induced obese mice. Evidence-Based Complementary Alternative Medicine 2012 2012 6 272710 10.1155/2012/272710
10. Lee J., Jung E., Lee J., Kim S., Huh S., Kim Y., Kim Y., Byun S. Y., Kim Y.-S., Park D., Isorhamnetin represses adipogenesis in 3T3-L1 cells. Obesity 2009 17 2 226 232 2-s2.0-58849105824 10.1038/oby.2008.472
11. Hsu C.-L., Yen G.-C., Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Molecular Nutrition and Food Research 2008 52 1 53 61 2-s2.0-38949134138 10.1002/mnfr.200700393 (Pubitemid 351211802)
12. Ahn J., Lee H., Kim S., Park J., Ha T., The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochemical and Biophysical Research Communications 2008 373 545 549
13. Harmon A. W., Harp J. B., Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. American Journal of Physiology-Cell Physiology 2001 280 4 C807 C813 2-s2.0-0034996015
14. Ksouri R., Megdiche Ksouri W., Jallali I., Debez A., Magné C., Hiroko I., Abdelly C., Medicinal halophytes: potent source of health promoting biomolecules with medical, nutraceutical and food applications. Critical Reviews in Biotechnology 2012 32 4 289 326
15. Ksouri R., Falleh H., Megdiche W., Trabelsi N., Mhamdi B., Chaieb K., Bakrouf A., Magné C., Abdelly C., Antioxidant and antimicrobial activities of the edible medicinal halophyte Tamarix gallica L. and related polyphenolic constituents. Food and Chemical Toxicology 2009 47 8 2083 2091 2-s2.0-68949147784 10.1016/j.fct.2009.05.040
16. Ivanova D., Gerova D., Chervenkov T., Yankova T., Polyphenols and antioxidant capacity of Bulgarian medicinal plants. Journal of Ethnopharmacology 2005 96 1-2 145 150 2-s2.0-9644302385 10.1016/j.jep.2004.08.033 (Pubitemid 39575044)
17. le Floc'h E., Contribution a une etude Ethnobotanique de la Flore tunisienne 1952 Ministere de l enseignement Superieure et de la Recherche Scientifique
18. El-Alali A., AlZoubi A., Gharaibeh M., Tawaha K., Alali F. Q., Phytochemical and biological investigation of Nitraria retusa asch. Jordan Journal of Pharmaceutical Sciences 2012 5 2
19. Boubaker J., Ben Sghaier M., Ines S., Ghedira K., Chekir-Ghedira L., Isorhamnetin 3-O-robinobioside from Nitraria retusa leaves enhance antioxidant and antigenotoxic activity in human chronic myelogenous leukemia cell line K562. BMC Complementary and Alternative Medicine 2012 12 135
20. Boubaker J., Skandrani I., Bouhlel I., sghaier M. B., Neffati A., Ghedira K., Chekir-Ghedira L., Mutagenic, antimutagenic and antioxidant potency of leaf extracts from Nitraria retusa. Food and Chemical Toxicology 2010 48 8-9 2283 2290 2-s2.0-77955052092 10.1016/j.fct.2010.05.061
21. Han J., Isoda H., Capsaicin induced the upregulation of transcriptional and translational expression of glycolytic enzymes related to energy metabolism in human intestinal epithelial cells. Journal of Agricultural and Food Chemistry 2009 57 23 11148 11153 2-s2.0-72449140073 10.1021/jf901943q
22. Galgani J., Ravussin E., Energy metabolism, fuel selection and body weight regulation. International Journal of Obesity 2008 32 7 S109 S119 2-s2.0-58149493406 10.1038/ijo.2008.246
23. Hadj Salem J., Chevalot I., Harscoat-Schiavo C., Paris C., Fick M., Humeau C., Biological activities of flavonoids from Nitraria retusa (Forssk.) Asch. and their acylated derivatives. Food Chemistry 2011 124 2 486 494 2-s2.0-77955774729 10.1016/j.foodchem.2010.06.059
24. Hussein S. R., Kawashty S. A., Tantawy M. E., Saleh N. A. M., Chemosystematic studies of Nitraria retusa and selected taxa of Zygophyllaceae in Egypt. Plant Systematics and Evolution 2009 277 3-4 251 264 2-s2.0-59449088151 10.1007/s00606-008-0108-x
25. Pandey K. B., Rizvi S. I., Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Medicine and Cellular Longevity 2009 2 5 270 278 2-s2.0-77953474824 10.4161/oxim.2.5.9498
26. Hsu C.-L., Yen G.-C., Inhibitory effect of phenolic acids on the proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity. Journal of Agricultural and Food Chemistry 2006 54 12 4191 4197 2-s2.0-33745764186 10.1021/jf0609882 (Pubitemid 44013321)
27. Yang J.-Y., Della-Fera M. A., Rayalam S., Ambati S., Hartzell D. L., Park H. J., Baile C. A., Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sciences 2008 82 19-20 1032 1039 2-s2.0-42649130051 10.1016/j.lfs.2008.03. 003
28. Aguirre L., Arias N., Macarulla M. T., Gracia A., Portillo M. P., Beneficial effects of quercetin on obesity and diabetes. The Open Nutraceuticals Journal 2011 4 189 198 2-s2.0-80455149952 10.2174/1876396001104010189
29. de Santi C., Pietrabissa A., Mosca F., Spisni R., Pacifici G. M., Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 2000 30 9 857 866 2-s2.0-0033777342
30. Liang Y.-C., Tsai S.-H., Chen L., Lin-Shiau S.-Y., Lin J.-K., Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochemical Pharmacology 2003 65 7 1053 1060 2-s2.0-0037378391 10.1016/S0006-2952(03)00011-X (Pubitemid 36349745)
31. Haider U. G. B., Sorescu D., Griendling K. K., Vollmar A. M., Dirsch V. M., Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Molecular Pharmacology 2003 63 4 925 932 2-s2.0-0037379690 10.1124/mol.63.4.925 (Pubitemid 36369000)
32. Park H. J., Yang J.-Y., Ambati S., Della-Fera M. A., Hausman D. B., Rayalam S., Baile C. A., Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. Journal of Medicinal Food 2008 11 4 773 783 2-s2.0-57349156235 10.1089/jmf.2008.0077
33. Matsuda H., Kogami Y., Nakamura S., Sugiyama T., Ueno T., Yoshikawa M., Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells. Bioorganic and Medicinal Chemistry 2011 19 9 2835 2841 2-s2.0-79955465916 10.1016/j.bmc.2011.03.040
34. Lin X., Schonfeld G., Yue P., Chen Z., Hepatic fatty acid synthesis is suppressed in mice with fatty livers due to targeted apolipoprotein B38.9 Mutation. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 3 476 482 2-s2.0-0036124635 10.1161/hq0302.105271 (Pubitemid 34218757)
35. Tirosh A., Shai I., Bitzur R., Kochba I., Tekes-Manova D., Israeli E., Shochat T., Rudich A., Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care Journal 2008 31 10 2032 2037 2-s2.0-56149103696 10.2337/dc08-0825
36. Mulvihill E. E., Allister E. M., Sutherland B. G., Telford D. E., Sawyez C. G., Edwards J. Y., Markle J. M., Hegele R. A., Huff M. W., Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes Journal 2009 58 10 2198 2210 2-s2.0-70349651441 10.2337/db09-0634
37. Hajer G. R., van Haeften T. W., Visseren F. L. J., Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. European Heart Journal 2008 29 24 2959 2971 2-s2.0-58049219012 10.1093/eurheartj/ehn387
38. Maglich J. M., Lobe D. C., Moore J. T., The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. Journal of Lipid Research 2009 50 3 439 445 2-s2.0-64249083389 10.1194/jlr.M800226-JLR200
39. Wakil S. J., Abu-Elheiga L. A., Fatty acid metabolism: target for metabolic syndrome. Journal of Lipid Research 2009 50 S138 S143 2-s2.0-66349099340 10.1194/jlr.R800079-JLR200
40. Yamamoto K., Shimano H., Shimada M., Kawamura M., Gotoda T., Harada K., Ohsuga J.-I., Yazaki Y., Yamada N., Overexpression of apolipoprotein E prevents development of diabetic hyperlipidemia in transgenic mice. Diabetes 1995 44 5 580 585 2-s2.0-0029043716
41. Wang H., Eckel R. H., Lipoprotein lipase: from gene to obesity. American Journal of Physiology-Endocrinology and Metabolism 2009 297 2 E271 E288 2-s2.0-66849106857 10.1152/ajpendo.90920.2008
42. Lee J., Lee J., Jung E., Hwang W., Kim Y.-S., Park D., Isorhamnetin-induced anti-adipogenesis is mediated by stabilization of β -catenin protein. Life Sciences 2010 86 11-12 416 423 2-s2.0-77949542435 10.1016/j.lfs.2010.01.012
43. Yoshida H., Takamura N., Shuto T., Ogata K., Tokunaga J., Kawai K., Kai H., The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF- α in mouse adipocytes. Biochemical and Biophysical Research Communications 2010 394 3 728 732 2-s2.0-77950517855 10.1016/j.bbrc.2010.03.060
44. Ahn J., Lee H., Kim S., Park J., Ha T., The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochemical and Biophysical Research Communications 2008 373 4 545 549 2-s2.0-46149087077 10.1016/j.bbrc.2008.06.077